Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Japanese Pharmaceutical Industry PDF full book. Access full book title The Japanese Pharmaceutical Industry by Maki Umemura. Download full books in PDF and EPUB format.
Author: Maki Umemura Publisher: Routledge ISBN: 1136828249 Category : Business & Economics Languages : en Pages : 245
Book Description
This book explores why Japan, despite being a world leader in many high technology industries such as automobiles and consumer electronics, is only a minor player in the global pharmaceutical industry. Japan provides a huge market for pharmaceuticals as the second largest consumer of prescription drugs after the United States, and is a massive importer of prescription drugs, relying on discoveries made elsewhere. This book charts the development of the industry, from the devastation resulting from the Second World War to its performance in the present day. Focusing in particular on antibiotics and anticancer drugs, the book analyses factors that have prevented Japan from leading the rapid advances in science and technology that have occurred globally over recent decades. Looking at the pharmaceutical industry, the book argues that the Japanese government’s research and development policies were not sufficiently incentivising. It also shows how the nature of capitalism in Japan - which featured close relations between government and industry as well as between and within firms - was appropriate for nurturing industrial development in the immediate post-war decades, but became much less effective in later years.
Author: Maki Umemura Publisher: Routledge ISBN: 1136828249 Category : Business & Economics Languages : en Pages : 245
Book Description
This book explores why Japan, despite being a world leader in many high technology industries such as automobiles and consumer electronics, is only a minor player in the global pharmaceutical industry. Japan provides a huge market for pharmaceuticals as the second largest consumer of prescription drugs after the United States, and is a massive importer of prescription drugs, relying on discoveries made elsewhere. This book charts the development of the industry, from the devastation resulting from the Second World War to its performance in the present day. Focusing in particular on antibiotics and anticancer drugs, the book analyses factors that have prevented Japan from leading the rapid advances in science and technology that have occurred globally over recent decades. Looking at the pharmaceutical industry, the book argues that the Japanese government’s research and development policies were not sufficiently incentivising. It also shows how the nature of capitalism in Japan - which featured close relations between government and industry as well as between and within firms - was appropriate for nurturing industrial development in the immediate post-war decades, but became much less effective in later years.
Author: Publisher: ScholarlyEditions ISBN: 1464922853 Category : Business & Economics Languages : en Pages : 330
Book Description
Pharmaceutical Companies / 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Pharmaceutical Companies. The editors have built Pharmaceutical Companies: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Pharmaceutical Companies in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Pharmaceutical Companies: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author: M. Yamada Publisher: Springer ISBN: 0230373690 Category : Business & Economics Languages : en Pages : 328
Book Description
A challenge to superficial and mistaken assumptions about Japan's top management among foreign businessmen, such as Japanese management's supposed long-term outlook, slow decision-making, and strong desire for new technologies. The hard facts to destroy these myths is provided, based on interviews with managers in 100 top Japanese firms. Current Japanese management practice is placed in the context of the business relations developed to rebuild the shattered economy after World War Two, and the monumental changes which took place after the crash of the bubble economy in 1992. New scenarios for Japan's future are discussed and examined.
Author: Chinese University of Hong Kong Publisher: ISBN: 9789881904119 Category : Clinical trials Languages : en Pages : 153
Book Description
The idea for this manual came from Pfizer in the US, which provided the Clinical Trials Centre at The University of Hong Kong, Hong Kong SAR, PR China with a nonbinding grant for its development. The general project layout protocol was accepted by Pfizer in July 2009. Pfizer has not in any way interfered with the project, except for providing nonbinding comments to the final product. The entire text of this manual was written by Johan PE Karlberg. Marjorie A Speers provided considerable and essential comments on the contents and the first and subsequent drafts. A group of international human research protection experts mostly working in non-profit institutions or organisations - see Contributors for details - reviewed and provided important comments on the contents and final draft. It was solely created with the intention to promote human research protection of participants in clinical trials. This manual will be translated into numerous languages and is provided free of charge as an electronic file over the Internet (http://www.ClinicalTrialMagnifier.com) and offered in print for a fee. The objective beyond this project is to establish educational activities, developed around the manual, and jointly organised with leading academic institutions worldwide.
Author: Collectif Publisher: OECD ISBN: 9264266445 Category : Social Science Languages : en Pages : 239
Book Description
This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money. The analysis considers how health systems and policy makers should adapt in terms of development, assessment and uptake of health technologies. The first chapter provides an examination of adoption and impact of medical technology in the past and how health systems are preparing for continuation of such trends in the future. Subsequent chapters examine the need to balance innovation, value, and access for pharmaceuticals and medical devices, respectively, followed by a consideration of their combined promise in the area of precision medicine. The final chapter examines how health systems can make better use of health data and digital technologies. The report focuses on opportunities linked to new and emerging technologies as well as current challenges faced by policy makers, and suggests a new governance framework to address these challenges.
Author: Maki Umemura
Author: Maki Umemura
Author: 
Author: 
Author: 
Author: M. Yamada
Author: 
Author: 
Author: 
Author: Chinese University of Hong Kong
Author: Collectif